Sponsors (9)
This bill directs federal attention and coordinated research toward Down syndrome—potentially improving diagnosis, care, and inclusion for people with Down syndrome and their families—while creating trade-offs in federal spending, privacy risks, and possible diversion of research resources unless budgets and safeguards are adjusted.
People with Down syndrome (and related patient groups) will see increased research and clinical trials focused on their conditions, leading to better diagnosis, treatments, and health outcomes.
Families of individuals with Down syndrome will gain research-backed improvements in quality-of-life supports and services as research priorities and findings guide program development.
Clinicians and health systems will obtain real-world evidence and data to inform clinical decision-making for Down syndrome and co-occurring conditions, improving care delivery.
Participants and people with Down syndrome could face privacy and consent risks from assembling large study populations and sharing real-world clinical data.
Focusing research funds and attention on Down syndrome could divert NIH resources away from other conditions if overall budgets are not increased.
Taxpayers may experience increased federal spending to establish and maintain coordinated research programs, grants, and administrative activities.
Based on analysis of 3 sections of legislative text.
Directs NIH to establish a coordinated research, training, and clinical program focused on Down syndrome, including inclusive trials, biomarker work, and biennial reports to Congress.
Creates a new NIH-led research program to coordinate, expand, and support research, training, and clinical studies focused on Down syndrome. The program will fund and coordinate basic science on chromosome 21, larger study populations, inclusive clinical trials, biomarkers, studies of common co-occurring conditions (like Alzheimer’s and autoimmune disease), quality-of-life research, technical assistance for grantees, and biennial reporting to Congress about funded research and resulting evidence. The law directs NIH to coordinate across its institutes, centers, and other federal partners to reduce duplication, provide support to researchers, and compile a catalog of projects and real-world evidence that can inform clinical care for people with Down syndrome. It authorizes the program but does not specify appropriations in the text provided.
Introduced May 21, 2025 by John Wright Hickenlooper · Last progress May 21, 2025